Voyager Therapeutics (VYGR) Assets Average (2015 - 2026)

Voyager Therapeutics has disclosed Assets Average across 12 years of filings, most recently posting $208.5 million for Q2 2026.

• In Q2 2026, Assets Average fell 38.24% year-over-year to $208.5 million; the TTM figure through Jun 2026 stood at $208.5 million (down 38.24% YoY), while the FY2025 annual figure was $322.7 million, down 13.3% from the prior year.
• Assets Average came in at $208.5 million for Q2 2026 at Voyager Therapeutics, down from $235.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $452.9 million in Q2 2024 to a low of $170.9 million in Q4 2022.
• Average Assets Average over 5 years is $300.5 million, with a median of $305.2 million recorded in 2023.
• Year-over-year, Assets Average soared 88.96% in 2023 and tumbled 38.24% in 2026.
• Over 5 years, Assets Average stood at $170.9 million in 2022, then jumped by 88.96% to $323.0 million in 2023, then rose by 26.81% to $409.5 million in 2024, then tumbled by 34.0% to $270.3 million in 2025, then fell by 22.85% to $208.5 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $208.5 million in Q2 2026, $235.8 million in Q1 2026, and $270.3 million in Q4 2025.